Zynerba Pharmaceuticals (ZYNE)

[Bescaredxx]

FYI, the only partnership plans will be way down the rd and will be a marketing partner for O/A. Mainly because its such a broad market.

FXS id their baby right now and they plan to bring it to market all on their own. Phase 3 costing only 5+ mill or so..

Epilepsy update, now in advanced open label study where they are seeing close to 50% overall reduction in seizures. Trial was a failure at first but have worked out the kinks and many original patients remain on the program. Company has basically decided to move forward and plans on restructuring a new phase II study and focus it more on children. As the drug seems to have excellent response in younger brains.

Meeting with the FDA will be taking place before year end to discus restructuring of a phase 3 O/A to address secondary end points and focus the study on men.

ZYN001 update, still on target to release phase 1 data before year end. the company has taken time testing more dosage levels and time frames making phase 2 and 3 much easier to work with flexibility wise. Allowing for more options with dosing/endpoints.
Phase 2 enrollment will follow first half 2018.

Earnings and summary should be out 2nd week of Nov.

Estimated revenue on first year approval of zyn001 & zyn002 is approx 1.5+ billion dollars putting a non diluted target price of $115 a share.

Company currently has 78 mil in cash and private investors that will support phase 3 studies out to 2019!

Cheers. ????